News &
Media
Cannabiz: Autism data hits ‘registration benchmark’ as Neurotech prepares for Phase III clinical trial
View More: Cannabiz: Autism data hits ‘registration benchmark’ as Neurotech prepares for Phase III clinical trialNWR Virtual Healthcare Conference Presentation
View More: NWR Virtual Healthcare Conference PresentationHerald Sun: Could this new cannabis oil be a global first for treating autism?
View More: Herald Sun: Could this new cannabis oil be a global first for treating autism?Stockhead 2026 Health & Biotech Investor Guide
View More: Stockhead 2026 Health & Biotech Investor GuideStockhead: Neurotech partners with University of Sydney to advance Rett syndrome program
View More: Stockhead: Neurotech partners with University of Sydney to advance Rett syndrome programStockhead: Neurotech gets crucial ethics approval to start phase III autism trial
View More: Stockhead: Neurotech gets crucial ethics approval to start phase III autism trialStockhead: Peer-reviewed PANS data strengthens the case for Neurotech’s NTI164
View More: Stockhead: Peer-reviewed PANS data strengthens the case for Neurotech’s NTI164Stockhead: Neurotech hopes to ride the medical cannabis deregulation Trump Bump
View More: Stockhead: Neurotech hopes to ride the medical cannabis deregulation Trump BumpStockhead: Neurotech raising $4 million to drive NTI164 development
View More: Stockhead: Neurotech raising $4 million to drive NTI164 development